Espoir Pour la Santé

MTBVAC chez le nouveau-né: Étude clinique de Phase 2a (sécurité et immunogénicité) et renforcement des capacités pour soutenir les futurs essais d'efficacité du vaccin dans les régions endémiques de la tuberculose en Afrique subsaharienne.
Le besoin de développer de nouvelles formulations vaccinales contre la tuberculose est devenu une priorité de santé publique. Le centre EPLS est partenaire du programme “MTBAC-Newborns” qui sera finance de 2018 à 2020 par la Communauté Européenne à travers son programme EDCTP 2. Ce candidat vaccin, découvert par le professeur Carlos Martin de l’Université de Saragosse (Espagne), est développé au sein de ce programme par consortium de plusieurs partenaires :
Entreprise de biotechnologie Biofabri (Espagne) (coordination)
TuBerculosis Vaccine Initiative (TBVI) (Hollande)
Universidad de Zaragoza (Espagne)
University of Cap Town (Afrique du Sud)
Centre de Recherche Biomédicale Espoir Pour La Santé (BRC-EPLS) / Sénégal
Institut Pasteur de Madagascar (IPM)

MTBVAC in Newborns: Phase 2a Dose-Defining Safety and Immunogenicity Study and Capacity Building to Support Vaccine Efficacy Trials in Tuberculosis-Endemic Regions of Sub-Saharan Africa.
The need to develop new vaccine formulations against tuberculosis has become a public health priority. The EPLS Center is a partner of the "MTBAC-Newborns" program. The European Community through its EDCTP 2 program will fund the project from 2018 to 2020. The MTBVAC vaccine, discovered by Professor Carlos Martin from the University of Zaragoza, Spain, is developed within this program by a consortium of several partners:
Biotech Biofabri / Spain
TuBerculosis Vaccine Initiative (TBVI)
Universidad de Zaragoza / Spain
University of CapeTown (UCT) / South Africa
Biomedical Research Canter Espoir Pour La Santé (BRC-EPLS) / Senegal
Institut Pasteur de Madagascar (IPM)

Le Centre de Recherche Biomédicale EPLS est devenu laboratoire associé de l'Institut Pasteur de Lille en 2016 par volonté commune d'accroitre le potentiel de recherche des deux institutions. Une antenne de EPLS est en activité au Centre d'Infection et d'Immunologie de Lille à l'Institut Pasteur.

The Biomedical Research Center EPLS has become an associate laboratory of the Institut Pasteur in Lille in 2016 through a common desire to increase the research potential of both institutions. An antenna of EPLS is active at the Center of Infection and Immunology of Lille at the Institut Pasteur.

"River of Hope" is finally available online! Watch this fascinating story about humans, water, prawns and health! via Lifelines - Al Jazeera

River of Hope Can prawns stop a massive outbreak of the killer schistosomiasis (bilharzia) parasite in Sudan?

Girls education: first step for better lives!

To live long, healthy lives, girls must first be educated. The longer a girl stays in school, the more likely she is to marry later, survive childbirth, and raise healthy children. Education plays an essential role in economic growth and reducing poverty, and contributes to peace and security. http://bit.ly/1cRta8P

Grand Challenges Canada , a program of the government of Canada in cooperation with the Bill & Melinda Gates Foundation chose to highlight Project Crevette as their featured program on World Health Day ! How cool is that ?!

http://www.grandchallenges.ca/2014/small-bites-big-threat/

Small bites, big threat: Canada champions the fight against impact of vector-borne diseases on... April 7 is the World Health Day, themed Small bites; Big threats, highlighting vector-borne diseases. Grand Challenges Canada, which is funded by the Government

Small bite Big threat!
World Health Day 2014: Protect yourself from vector-borne diseases

More than half of the world's population is at risk from vector-borne diseases such as malaria and dengue. Yet, we can protect ourselves and our families by taking simple preventive measures, including vaccination. This World Health Organization infographic highlights a number of these.

Life cycle: Schistosomiasis An annual drug dosage can treat the disease but it recurs when people use infected water for their daily needs.

The burden of MDR in an infography

Le saviez-vous?

5 choses que vous ignorez sur la tuberculose SANTE - Nous pensions cette maladie disparue de nos vies depuis des années, mais en 2012, 8,6 millions de personnes ont développé la tuberculose et 1,3 million e...

Building Research Capacity in Africa: Equity + Global Health Collaborations

Read this essay on Plos Med to learn more : http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001612

Global health has increased the number of high-income country investigators conducting research in low- and middle-income countries.

Partnerships with local collaborators rather than extractive research are needed.

Low- and middle-income countries have to take an active role in leading or directing these research collaborations in order to maximize the benefits and minimize the harm of inherently inequitable relationships.

This essay explores lessons from effective and equitable relationships that exist between African countries and high-income countries.